Search results for SEARCH[Study] TILT[Study:StudyFirstPostDate] AREA[InterventionSearch] Nelfinavir mesylate - ICH GCP

Clinical Trials: SEARCH[Study] TILT[Study:StudyFirstPostDate] AREA[InterventionSearch] Nelfinavir mesylate

NCTID/Status

Study

Last Changed

NCT03077451
Recruiting

Nelfinavir Mesylate in Treating Patients With Kaposi Sarcoma
Conditions: Recurrent Kaposi Sarcoma; Skin Kaposi Sarcoma
Intervention: Laboratory Biomarker Analysis, Nelfinavir Mesylate

July 1, 2019

NCT02080416
Terminated

Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors
Conditions: Non-Hodgkin Lymphoma; Hodgkin Lymphoma; Kaposi Sarcoma; Gastric Cancer; Nasopharyngeal Cancer; EBV; Castleman Disease
Intervention: Nelfinavir

June 8, 2016

NCT02066311
Completed

Nelfinavir in Systemic Lupus Erythematosus
Conditions: Systemic Lupus Erythematosus
Intervention: Nelfinavir

July 25, 2018

NCT01925378
Recruiting

A Phase II Single-arm Intervention Trial of Nelfinavir in Patients With Grade 2/3 or 3 Cervical Intraepithelial Neoplasia
Conditions: Cervical Dysplasia
Intervention: Nelfinavir

February 22, 2017

NCT00704600
Completed

Nelfinavir, a Phase I/Phase II Rectal Cancer Study
Conditions: Colorectal Cancer; Colorectal Carcinoma; Colorectal Tumors; Neoplasms, Colorectal
Intervention: Nelfinavir

December 5, 2014

NCT01065844
Completed

Nelfinavir in Recurrent Adenoid Cystic Cancer of the Head and Neck
Conditions: Carcinoma, Adenoid Cystic; Head and Neck Neoplasms
Intervention: Nelfinavir

September 24, 2019

NCT01447589
Withdrawn

Radical Lung Radiotherapy Plus Nelfinavir
Conditions: Lung Cancer
Intervention: Nelfinavir, Radical Radiotherapy

June 22, 2016

NCT00246610
Completed

Safety Of VIRACEPT® 625mg Administered To HIV-Infected Women During Pregnancy
Conditions: HIV Infection
Intervention: Nelfinavir Mesylate, 625 Mg

April 26, 2011

NCT03422874
Withdrawn

Dose Escalation Study of Nelfinavir Plus MLN9708 in Patients With Advanced Solid Tumors or Lymphoma
Conditions: Neoplasms; Lymphoma
Intervention: MLN9708, Nelfinavir

January 30, 2018

NCT01728779
Active, not recruiting

Stereotactic Body Radiation With Nelfinavir for Oligometastases
Conditions: Oligometastases
Intervention: Nelfinavir, Stereotactic Body Radiation (SBRT)

November 5, 2018

NCT00791336
Terminated

Study to Evaluate Using Nelfinavir With Chemoradiation for Non-small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung
Intervention: Nelfinavir

June 29, 2017

NCT01164709
Completed

Nelfinavir Mesylate and Bortezomib in Treating Patients With Relapsed or Progressive Advanced Hematologic Cancer
Conditions: Leukemia; Lymphoma; Mature T-cell and Nk-cell Neoplasms; Multiple Myeloma and Plasma Cell Neoplasm
Intervention: Bortezomib, Nelfinavir Mesylate

May 14, 2019

NCT01079286
Completed

Study of Nelfinavir and Temsirolimus in Patients With Advanced Cancers
Conditions: Renal Cell Cancer; Cancer
Intervention: Nelfinavir And Temsirolimus

July 12, 2013

NCT03829020
Recruiting

Metformin and Nelfinavir in Treating Patients With Relapsed and/or Refractory Multiple Myeloma
Conditions: Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
Intervention: Bortezomib, Metformin Hydrochloride, Nelfinavir Mesylate

April 22, 2019

NCT01086332
Terminated

Evaluation of Nelfinavir and Chemoradiation for Pancreatic Cancer
Conditions: Pancreatic Neoplasms
Intervention: Nelfinavir, Gemcitabine

November 8, 2018

NCT01555281
Active, not recruiting

Nelfinavir and Lenalidomide/Dexamethasone in Progressive Multiple Myeloma
Conditions: Multiple Myeloma
Intervention: Nelfinavir, Lenalidomide, Dexamethasone

May 20, 2019

NCT02188537
Completed

Nelfinavir as Bortezomib-sensitizing Drug in Patients With Proteasome Inhibitor-nonresponsive Myeloma
Conditions: Myeloma
Intervention: Nelfinavir, Bortezomib, Dexamethasone

June 24, 2019

NCT01108666
Terminated

Proton Beam Radiation With Concurrent Chemotherapy and Nelfinavir for Inoperable Stage III Non Small Cell Lung Cancer (NSCLC)
Conditions: Non Small Cell Lung Cancer
Intervention: Nelfinavir

May 30, 2019

NCT00002165
Completed

Viracept Expanded Access Program
Conditions: HIV Infections
Intervention: Nelfinavir Mesylate

June 23, 2005

NCT00002164
Completed

Phase I Study of Safety, Tolerability, and Pharmacokinetics of Viracept in HIV-1 Infected Children and Exposed Infants
Conditions: HIV Infections
Intervention: Nelfinavir Mesylate

June 23, 2005

NCT00694837
Completed

Study With Nelfinavir and Combined Radiochemotherapy for Glioblastoma
Conditions: Glioblastoma
Intervention: Nelfinavir

April 9, 2015

NCT00002169
Completed

A Study of Viracept in AIDS Patients With Cytomegalovirus Retinitis
Conditions: Cytomegalovirus Retinitis; HIV Infections
Intervention: Nelfinavir Mesylate

June 23, 2005

NCT00002171
Completed

A Study of Viracept in HIV-Positive Women
Conditions: HIV Infections
Intervention: Nelfinavir Mesylate

June 23, 2005

NCT00002170
Completed

A Study of Viracept in AIDS Patients With Mycobacterium Avium Complex Disease (MAC)
Conditions: Mycobacterium Avium-Intracellulare Infection; HIV Infections
Intervention: Nelfinavir Mesylate

June 23, 2005

NCT00002185
Completed

A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3
Conditions: Sarcoma, Kaposi; HIV Infections
Intervention: Nelfinavir Mesylate

June 23, 2005

NCT01445106
Completed

A Phase I Trial of Nelfinavir (Viracept ) in Adults With Solid Tumors
Conditions: Solid Tumors
Intervention: Nelfinavir, Nelfinavir Mesylate

October 12, 2019

NCT03256916
Recruiting

Radiosensitizing Effect of Nelfinavir in Locally Advanced Carcinoma of Cervix
Conditions: Carcinoma Cervix, Stage III
Intervention: Nelfinavir, Cisplatin, Pelvic EBRT And Brachytherapy

June 22, 2019

NCT03050060
Suspended

Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, Pembrolizumab, Nivolumab and Atezolizumab in Treating Patients With Advanced Melanoma, Lung, or Kidney Cancer
Conditions: Metastatic Kidney Carcinoma; Recurrent Melanoma; Recurrent Lung Non-Small Cell Carcinoma; Recurrent Renal Cell Carcinoma; Stage IV Cutaneous Melanoma AJCC v6 and v7; Stage IV Non-Small Cell Lung Cancer AJCC v7; Stage IV Renal Cell Cancer AJCC v7
Intervention: Atezolizumab, Hypofractionated Radiation Therapy, Laboratory Biomarker Analysis, Nelfinavir Mesylate, Nivolumab, Pembrolizumab, Nelfinavir

May 15, 2019

NCT00205283
Completed

Nelfinavir and M8 Drug-level Monitoring in HIV-1 Infection
Conditions: HIV Infections
Intervention: Nelfinavir

March 20, 2019

NCT00002201
Completed

A Study of Ritonavir (ABT-538) When Used With Nelfinavir in HIV-Infected Patients
Conditions: HIV Infections
Intervention: Ritonavir, Nelfinavir Mesylate

February 19, 2009

NCT00002375
Completed

Safety and Effectiveness of Giving Indinavir and Nelfinavir to HIV-Infected Patients
Conditions: HIV Infections
Intervention: Indinavir Sulfate, Nelfinavir Mesylate

June 23, 2005

NCT00233948
Terminated

Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable Liposarcoma
Conditions: Adult Liposarcoma; Recurrent Adult Soft Tissue Sarcoma; Stage III Adult Soft Tissue Sarcoma; Stage IV Adult Soft Tissue Sarcoma
Intervention: Nelfinavir Mesylate, Biopsy, Laboratory Biomarker Analysis, Pharmacological Study, Gene Expression Analysis, Western Blotting, Reverse Transcriptase-polymerase Chain Reaction, Immunoenzyme Technique

March 30, 2015

NCT00312182
Completed

Thorough QT Study of Nelfinavir
Conditions: Healthy Volunteers
Intervention: Nelfinavir

April 9, 2009

NCT00000893
Completed

Safety, Tolerability, and Anti-HIV Activity of DMP 266 (Efavirenz) in Combination With Nelfinavir in HIV-Positive Children
Conditions: HIV Infections
Intervention: Nelfinavir Mesylate, Efavirenz

June 2, 2015

NCT00346619
Completed

Determining the Amount of Time Needed for Nelfinavir to Boost the Immune System in Adults
Conditions: Immune Response
Intervention: Nelfinavir

January 19, 2010

NCT01020292
Completed

A Trial of the Protease Inhibitor Nelfinavir and Concurrent Radiation and Temozolomide in Patients With WHO Grade IV Glioma
Conditions: Glioma
Intervention: Nelfinavir

April 10, 2019

NCT01485731
Completed

Safety Study of Nelfinavir + Cisplatin + Pelvic Radiation Therapy to Treat Cervical Cancer
Conditions: Cervical Cancer
Intervention: Nelfinavir, Cisplatin, Pelvic External Beam Radiation Therapy, Brachytherapy, Pharmacokinetic Sampling, Cervical Biopsy, Pelvic Examination, Pap Smear, Audiogram, Proctoscopy, Cytoscopy, Renal Ultrasound, CT Scan, Whole Body PET/CT Scan

June 1, 2015

NCT00006211
Completed

A Study of Capravirine Plus VIRACEPT Plus Two Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Patients Who Failed Previous Anti-HIV Treatments
Conditions: HIV Infections
Intervention: Capravirine, Nelfinavir Mesylate

June 23, 2005

NCT00004985
Completed

Combination Treatment Using Capravirine (AG1549), Nelfinavir, and Two Nucleoside Reverse Transcriptase Inhibitors in HIV Patients Who Failed Initial Combination Therapy
Conditions: HIV Infections
Intervention: Capravirine, Nelfinavir Mesylate

June 23, 2005

NCT00457665
Completed

Mechanisms of Lipodystrophy in HIV-Infected Pateints
Conditions: HIV Infections
Intervention: Nelfinavir, Efavirenz

May 8, 2019

NCT00251030
Completed

A Study To Estimate The Effect Of Omeprazole On The Pharmacokinetics Of Nelfinavir In Healthy Subjects
Conditions: Healthy Volunteers
Intervention: Nelfinavir And Omeprazole

February 13, 2009

NCT00028067
Terminated

A Comparison of Atazanavir and Nelfinavir, Each in Combination With 2 NRTIs, in Patients Who Have Failed Treatments Without a Protease Inhibitor
Conditions: HIV Infections
Intervention: Atazanavir, Nelfinavir Mesylate

April 28, 2011

NCT02363829
Recruiting

A Study of Nelfinavir Added to Cisplatin Chemotherapy Concurrent With Pelvic Radiation for Locally Advanced Cervical Cancer (II-IVA)
Conditions: Uterine Cervix Cancer
Intervention: Nelfinavir, Cisplatin

September 26, 2018

NCT00002215
Completed

A Randomized, Double-Blind Study of MKC-442 Combined With Viracept in Patients Who Are Epivir + Retrovir Experienced and Are Protease Inhibitor- and Non-Nucleoside Reverse Transcriptase Inhibitor-Naive
Conditions: HIV Infections
Intervention: Emivirine, Nelfinavir Mesylate

June 23, 2005

NCT00915694
Terminated

Nelfinavir Mesylate, Radiation Therapy, and Temozolomide in Treating Patients With Glioblastoma Multiforme
Conditions: Brain and Central Nervous System Tumors
Intervention: Nelfinavir Mesylate, Temozolomide, Adjuvant Therapy, Radiation Therapy

April 22, 2019

NCT00650637
Terminated

A Study to Determine Effective Prophylaxis and Treatment of Nelfinavir-Associated Diarrhea
Conditions: Diarrhea
Intervention: Calcium Carbonate, Nelfinavir, Lamivudine, Loperamide, Calcium Carbonate Not Administered, Nelfinavir, Lamivudine + Zidovudine

June 3, 2011

NCT00541463
Completed

A Study of Indinavir Plus Ritonavir Plus Two NRTIs vs. Nelfinavir Plus Two NRTIs in HIV Positive Patients (0639-112)(COMPLETED)
Conditions: HIV Infections
Intervention: MK0639, Indinavir Sulfate / Duration Of Treatment: 48 Weeks, Comparator: Nelfinavir Mesylate / Duration Of Treatment: 48 Weeks

February 16, 2017

NCT00004999
Suspended

Effectiveness of a New Anti-HIV Drug (AG1549) Plus Viracept (Nelfinavir) Plus Combivir (Zidovudine/Lamivudine) in HIV-Infected Patients
Conditions: HIV Infections
Intervention: Lamivudine/Zidovudine, Capravirine, Nelfinavir Mesylate

June 23, 2005

NCT01959672
Active, not recruiting

Combination Chemotherapy With or Without Oregovomab Followed by Stereotactic Body Radiation Therapy and Nelfinavir Mesylate in Treating Patients With Locally Advanced Pancreatic Cancer
Conditions: Pancreatic Adenocarcinoma; Resectable Pancreatic Carcinoma; Stage I Pancreatic Cancer; Stage IA Pancreatic Cancer; Stage IB Pancreatic Cancer; Stage II Pancreatic Cancer; Stage IIA Pancreatic Cancer; Stage IIB Pancreatic Cancer; Stage III Pancreatic Cancer
Intervention: 4-Dimensional Computed Tomography, Fluorouracil, Gemcitabine Hydrochloride, Laboratory Biomarker Analysis, Leucovorin Calcium, Nelfinavir Mesylate, Oregovomab, Stereotactic Body Radiation Therapy, Therapeutic Conventional Surgery

April 24, 2018

NCT00023400
Completed

TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB
Conditions: HIV Infections; Tuberculosis
Intervention: Nelfinavir, Rifabutin

September 1, 2005

1 2 3 Next Last

Last Updated

The last updated date is the most recent date when changes to a clinical trial were submitted to ClinicalTrials.gov. There is often a delay of a few days before the updated trial is available on the clinical trials website.

Specify a From date to find the most recently changed trials. Specify both From and To dates to find trials changed during a certain period. If no dates are given, all trials will be included.

Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.

First Received

The first received date is the date when the clinical trial was first submitted to ClinicalTrials.gov. There is often a delay of a few days before the trial is available on the clinical trials website.

Clinical trial records are often updated after they have been published. The first received, last updated, start, and end dates are all displayed in the full text view of the clinical trial.

Specify a From date to find the most recent trials. Specify both From and To dates to find trials submitted during a certain period. If no dates are given, all trials will be included.

Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.

Safety Issue

If selected, restricts search results to those studies which have an outcome measure designated as a safety issue. Note that this is a poor estimate of the safety of a treatment or intervention, but it is all we have now.

Funded By

Studies are supported by one or more organizations called sponsors. Support includes contributions of facilities, expertise, and/or financial resources. All sponsors in the database have been assigned one of the following organization types:

National Institutes of Health (NIH)

Other U.S. Federal Agency - Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), Department of Veterans Affairs (VA), etc.

Industry - the pharmaceutical companies

University/Organization - all others, including community-based organizations

Click the check box to the left of each organization type that you wish to include in your search. You can select more than one organization type. If you do not select any type, all types will be included.

Study Phase

Most clinical trials are designated as phase 1, 2, 3, or 4, based on the type of questions that study is seeking to answer:

In Phase 1 (Phase I) clinical trials, researchers test a new drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.

In Phase 2 (Phase II) clinical trials, the study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety.

In Phase 3 (Phase III) clinical trials, the study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.

In Phase 4 (Phase IV) clinical trials, post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.

These phases are defined by the Food and Drug Administration in the Code of Federal Regulations.

Click the check box to the left of each study phase that you wish to include in your search. You can select more than one study phase. If you do not select a any phase, all phases will be included.

Age Group

Studies may be designed for participants of particular ages:

Children (birth-17 yrs old)

Adults (18-65 yrs old)

Senior (66+ yrs old)

Click the check box to the left of each age group that you wish to include in your search. You can select more than one age group. If you do not select a any group, all groups will be included.

Gender

Searches can be restricted to studies which accept female or male participants.

Location Terms

If you are interested in a specific city (such as Los Angeles) or facility name (such as the Mayo Clinic), enter it as a location term. Not all studies include this level of detail, but if they do, this will find them.

Countries and States

Trials are often conducted at many locations around the world. Select up to three locations to find trials conducted in specific countries. Some countries (currently limited to the United States, Canada, and Australia), locations can be narrowed further by selecting a state.

Study IDs

Each trial is assigned one or more identification numbers by the institute, agency, or organization sponsoring the trial. In addition, clinical trials assigns a unique NCT identifier of the form NCTxxxxxxxx where each x is a numeric digit. Use this box to search for a trial by NCT identifier or any other study identification numbers.

Examples:

NCT00001789
97-h-0197
ia0006
actg 076

Sponsor (Lead)

Use this box to specify the name of an institute, organization, or company that is conducting a trial.

It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.

A search in this area will check only the sponsor field. To also look for collaborators, use the Sponsor/Collaborators search box.

When the Exact Match checkbox is checked, the sponsor name in the study must exactly match the sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.

Examples:

National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb

Sponsor/Collaborators

Use this box to specify institutes, organizations, or companies that are conducting or otherwise supporting a trial.

It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.

Searching this area will look in both the sponsor field and in the collaborators field. To only look in the sponsor field, use the Sponsor (Lead) search box.

When the Exact Match checkbox is checked, the name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.

Examples:

National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb

Outcome Measures

Outcome measures are used to evaluate trial results. For example, an obesity treatment might be evaluated by a measure of weight loss after 6 months. Measures can also be used to quantify side effects, such as number of myocardial infarctions, number of patients with heart arrhythmia, number of suicides, etc.

Use this box to specify an outcome measure used to evaluate trial results.

Examples:

weight loss
heart failure
suicide

Interventions

Interventions refer to the drug, vaccine, procedure, device, or other potential treatment being studied. Interventions can also include less intrusive possibilities such as surveys, education, and interviews.

Use this box to specify drugs, devices, procedures, or vaccines used in a trial.

Examples:

clofibrate
cyclosporine
vitamin e

Conditions

Conditions usually refer to a disease, disorder, syndrome, illness, or injury. In ClinicalTrials.gov, conditions include any health issue worth studying, such as lifespan, quality of life, health risks, etc.

Use this box to specify the conditions being studied.

Examples:

lupus
heart attack
leukemia
risk factors for breast cancer

Study Type

There are three types of studies available in ClinicalTrials.gov:

Interventional:

Studies where individuals are assigned to receive specific interventions. Participants may receive diagnostic, therapeutic or other types of interventions. Assignment of the intervention may or may not be random. Individuals are tracked and biomedical and/or health outcomes are assessed.

Observational:

Studies without an intervention. Studies where biomedical and/or health outcomes are assessed in a pre-defined group of individuals. Participants may receive diagnostic, therapeutic, or other interventions, but the investigator does not assign specific interventions to the participants of the study.

Expanded Access:

Records describing the procedure for obtaining an experimental drug or device for patients who are failing on currently available treatments for their condition and also are unable to participate in ongoing clinical trials. Expanded Access records are used to register all types of non-protocol access to experimental treatments, including protocol exception, single-patient IND, treatment IND, compassionate use, emergency use, continued access and parallel track.

Study Results

Searches can be restricted to studies with or without results.

The inclusion of study results is a relatively new feature of ClinicalTrials.gov. Collection of results began in September of 2008. Almost all older studies and some newer studies do not include results. As time goes on, there will be more results available.

Recruitment Status

Also known as Enrollment Status.

Not all clinical trials in this database are accepting new participants. If you are looking for studies that are currently recruiting participants, will be recruiting in the future, or are about drugs that are available for expanded access, select Open Studies in the recruitment menu.

If you are interested in all trials, whether they are recruiting new participants or not, leave the menu with All Studies selected.

Trials may not be recruiting because they are full, completed, or halted for various reasons. In addition, some trials have very restrictive eligibility requirements and must seek participants by invitation only. To see these studies, Select Closed Studies in the recruitment menu.

Full list of all possible recruitment status values:

Open recruitment status values:

Recruiting,
Not yet recruiting, or
Available for expanded access.

Closed recruitment status values:

Active, not recruiting,
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.

Values are color coded (as shown) in the search results.

Search Terms

Use this box to specify general search terms found anywhere in the trial record.

Multiple terms can be separated by an AND (all uppercase).

Examples:

type ii diabetes
veterans affairs medical center
heart attacks in older adults
nhlbi AND heart disease
Cisplatin AND safety study

Help for Searching clinical trials

Help Topics:

Basic Search
Advanced Search
Refine Search
Search Expressions

Basic Search:

On the Basic Search page, enter a word or word(s) that you want to use to find studies. These may include diseases, interventions, and/or locations.

Medical terms are often several words long, such as Percutaneous Coronary Intervention. To only find studies where the words are together as a phrase, put the term in quotes (e.g., "Percutaneous Coronary Intervention"). If you search for a multi-word term without quotes, studies with all words together as a phrase will appear higher in the results list than studies where the words are separated and spread throughout the document. For example, a search for Heart Attack will list a study about,

Use of a Pacemaker Following a Heart Attack.

higher than the study,

Heart Defects and Transient Ischemic Attacks

A search for "Heart Attack" would not find the second study. Synonyms are known for some terms and are used where possible. For example, a search for Heart Attack will also find occurrences of Myocardial Infarction.

Advanced Search:

Many searches are a single term and can be performed with a few words in the search box. But, sometimes you need more control. Click on the Advanced Search tab (if starting a new search) or Refine Search tab (if modifying an existing search) to show additional search fields.

The additional search fields can be used to limit your search results. Note that it is not necessary to fill in all the fields, only those that are needed for your search. If you are finding too few studies, consider clearing a field and searching again.

Search Terms:

Performs a general search in all sections of the study record, including title, description, conditions, interventions, locations, etc. Terms in this field are searched the same as Basic Search.

Recruitment:

Limits search results to studies that are open or closed. New volunteers may be able to participate in open studies, but not closed studies.

Open recruitment status values:

Recruiting,
Not yet recruiting, or
Available for expanded access.

Closed recruitment status values:

Values are color coded (as shown) in the search results.

Study Results:

Limits search results based on whether the study has results or not:

All Studies,
Studies With Results, or
Studies Without Results

The inclusion of Study Results is a new feature of ClinicalTrials.gov. Only a few studies have results available.

Study Type:

Limits search results to any of the following study types:

Interventional,
Observational, or
Expanded Access

Conditions:

Performs a search on fields describing the diseases or conditions being studied.

Interventions:

Performs a search on fields listing the drugs or interventions being studied.

Outcomes Measures:

Performs a search on fields listing the outcome measures used to quantify study results.

Sponsor/Collaborators:

Performs a search on fields listing the sponsor and collaborators of a study.

When the Exact Match checkbox is checked, the sponsor/collaborator name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck in the sponsor/collaborator field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.

Sponsor (Lead):

Performs a search on the sponsor field of a study.

It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the "sponsor" is decided by the data provider.

When the Exact Match checkbox is checked, the lead sponsor name in the study must exactly match the lead sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.

Study IDs:

Performs a search on fields listing ID numbers.

Country/State:

Location Terms:

Finds studies in specific locations such as a city (Los Angeles) or facility (Mayo Clinic). Not all studies include this level of detail, but if they do, this will find them.

Gender:

Limits search results to those studies that accept female or male participants.

Age Group:

Limits search results to those studies that include at least one of the specified age ranges. More than one age group can be selected.

Phase:

Limits search results to studies that are labeled with at least one of the specified phases. More than one Phase can be selected.

Funded By:

Limits search results to studies that have at least one sponsor of the specified types. More than one sponsor type can be selected.

Safety Issue:

Limits search results to studies that have at least one outcome measure designated as a safety issue.

First Received:

Limits search results to studies that were received by clinical trials within a specified date range. The "From" or "To" field can be left blank.

Last Updated:

Limits search results to studies that were modified within a specified date range. The "From" or "To" field can be left blank.

Refine Search:

Searches display a list of studies found (List Results tab). If you are not content with the search results, click on the Refine Search tab at the top of the list to modify your search.

Add terms to empty fields to search within your current result. You can also add terms to fields that contain terms. For best results, use an AND (all upper case) as a separator between terms in the same field.

For example:

heart attack
heart attack AND aspirin
heart attack AND aspirin AND older adults
heart attack AND aspirin AND older adults AND California

When you are done making changes, click Search to display the new results.

Search Expressions:

Use AND (all upper case) to find study records that contain all terms connected by AND.
For example:

prostate cancer AND radiation
heart disease AND stroke AND California

Use OR (all upper case) to find study records that contain either term connected by OR.
For example:

Aspirin OR ibuprofen
heart disease OR heart attack

Use NOT (all upper case) to find study records that do not contain the term following NOT.
For example:

Immunodeficiency NOT AIDS

Likewise, AND, OR, NOT, and parentheses can be used to create more complicated search expressions.
For example:

prostate cancer AND NOT ( radiation OR homeopathic remedies )
( heart disease OR heart attack ) AND ( stroke OR clot )

Note that the use of AND and OR as logical operators can be confusing.
An appropriate search for a list such as,

Ear, Nose, and Throat Conditions

is the expression

( Ear OR Nose OR Throat ) AND Conditions

Fortunately, search will do a pretty good job of finding the right studies either way.

To search for AND as a word, instead of using it as an operator, put it in quotes.
Likewise, you can quote OR, NOT, and parentheses.

ICH GCP | Clinical Trials Registry

Clinical Trials: SEARCH[Study] TILT[Study:StudyFirstPostDate] AREA[InterventionSearch] Nelfinavir mesylate

Fill in any or all of the fields below.

Conditions

Rare Diseases

Drug
Interventions

Dietary
Supplements

Sponsor/
Collaborators

Locations

ICH GCP | Clinical Trials Registry

Clinical Trials: SEARCH[Study] TILT[Study:StudyFirstPostDate] AREA[InterventionSearch] Nelfinavir mesylate

Fill in any or all of the fields below.

Conditions

Rare Diseases

DrugInterventions

DietarySupplements

Sponsor/Collaborators

Locations

Drug
Interventions

Dietary
Supplements

Sponsor/
Collaborators